A clinical study of the combination of docetaxel, epirubicin and cyclophosphamide (TEC) as neoadjuvant chemotherapy regimen in the treatment of advanced breast cancer

doi:10.3969/j.issn.1674-3806.2009.11.16

Home>Articles>A clinical study of the combination of docetaxel, epirubicin and cyclophosphamide (TEC) as neoadjuvant chemotherapy regimen in the treatment of advanced breast cancer

DOI: 10.3969/j.issn.1674-3806.2009.11.16

A clinical study of the combination of docetaxel, epirubicin and cyclophosphamide (TEC) as neoadjuvant chemotherapy regimen in the treatment of advanced breast cancer

Machine-generated Keywords：

Publication Date：2009-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 1162-1165 )

CHINESE JOURNAL OF NEW CLINICAL MEDICINE

ISSN：1674-3806

Year, Vol.(Issue)：2009,2(11)